| # | Drug | Count |
|---|---|---|
| 0 | LEFLUNOMIDE | 9382 |
| 1 | METHOTREXATE SODIUM | 9382 |
| 2 | RITUXIMAB | 9375 |
| 3 | ADALIMUMAB | 9240 |
| 4 | TOCILIZUMAB | 9201 |
| 5 | PREDNISONE | 9174 |
| 6 | FOLIC ACID | 9103 |
| 7 | ALENDRONATE SODIUM | 9017 |
| 8 | METHOTREXATE | 8927 |
| 9 | ABATACEPT | 8847 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HYDROCHLORIDE | 120 | 0.6630 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 345 | 0.5391 |
| 2 | CORTISONE ACETATE | 6161 | 0.5020 |
| 3 | PSEUDOEPHEDRINE HCL | 5214 | 0.4760 |
| 4 | CAFFEINE CITRATE | 989 | 0.4374 |
| 5 | DESOXIMETASONE | 8003 | 0.4225 |
| 6 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 105 | 0.3488 |
| 7 | TRICLOSAN | 160 | 0.2996 |
| 8 | DICLOFENAC POTASSIUM TABLETS | 2229 | 0.2662 |
| 9 | CETIRIZINE HYDROCHLORIDE TABLETS | 6940 | 0.2305 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 10031 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 9620 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 9436 |
| 3 | Antirheumatic Agent [EPC] | 9384 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 9358 |
| 5 | Vitamin C [EPC] | 9320 |
| 6 | Vitamin B12 [EPC] | 9227 |
| 7 | Vitamin D [EPC] | 9108 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 8930 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 8847 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 9384 | 0.0895 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 9358 | 0.0692 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 8847 | 0.0643 |
| 3 | Aminosalicylate [EPC] | 8100 | 0.0614 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 3336 | 0.0404 |
| 5 | Interleukin-12 Antagonist [EPC] | 3867 | 0.0378 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 701 | 0.0360 |
| 7 | Vitamin D [EPC] | 9108 | 0.0304 |
| 8 | Vitamin B12 [EPC] | 9227 | 0.0287 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 9436 | 0.0286 |